Hurstak Emily E, Kushel Margot, Chang Jamie, Ceasar Rachel, Zamora Kara, Miaskowski Christine, Knight Kelly
a Department of Medicine , University of California San Francisco , San Francisco , California , USA.
b Division of General Internal Medicine , University of California San Francisco/Zuckerberg San Francisco General Hospital , San Francisco , California , USA.
Subst Abus. 2017 Apr-Jun;38(2):213-221. doi: 10.1080/08897077.2017.1296524. Epub 2017 Apr 10.
Patients with a history of substance use are more likely than those without substance use to experience chronic noncancer pain (CNCP), to be prescribed opioids, and to experience opioid misuse or overdose. Primary care practitioners (PCPs) in safety-net settings care for low-income patients with CNCP and substance use, usually without specialist consultation. To inform communication related to opioid risk, we explored PCPs' and patients' perceptions of the risks of chronic opioid therapy.
We conducted semistructured interviews with 23 PCPs and 46 of their patients, who had a history of CNCP and substance use. We recruited from 6 safety-net health care settings in the San Francisco Bay Area. We transcribed interviews verbatim and analyzed transcripts using grounded theory methodology.
(1) PCPs feared harming patients and the community by opioid prescribing. PCPs emphasized fear of opioid overdose. (2) Patients did not highlight concerns about the adverse health consequences of opioids, except for addiction. (3) Both patients and PCPs were concerned about PCPs' medicolegal risks related to opioid prescribing. (4) Patients reported feeling stigmatized by policies aimed at reducing opioid misuse.
We identified differences in how clinicians and patients perceive opioid risk. To improve the informed consent process for opioid therapy, patients and PCPs need to have a shared understanding of the risks of opioids and engage in discussions that promote patient autonomy and safety. As clinics implement opioid prescribing policies, clinicians must develop effective communication strategies in order to educate patients about opioid risks and decrease patients' experiences of stigma and discrimination.
有物质使用史的患者比无物质使用史的患者更有可能经历慢性非癌性疼痛(CNCP)、被开具阿片类药物处方以及出现阿片类药物滥用或过量情况。安全网环境中的初级保健医生(PCP)为患有CNCP和物质使用问题的低收入患者提供护理,通常无需专科医生会诊。为了为与阿片类药物风险相关的沟通提供信息,我们探讨了初级保健医生和患者对慢性阿片类药物治疗风险的认知。
我们对23名初级保健医生及其46名有CNCP和物质使用史的患者进行了半结构化访谈。我们从旧金山湾区的6个安全网医疗保健机构招募了参与者。我们逐字转录访谈内容,并使用扎根理论方法分析转录本。
(1)初级保健医生担心开具阿片类药物会对患者和社区造成伤害。初级保健医生强调担心阿片类药物过量。(2)患者除了对成瘾问题外,没有突出对阿片类药物不良健康后果的担忧。(3)患者和初级保健医生都担心初级保健医生在开具阿片类药物方面的法医学风险。(4)患者报告称,旨在减少阿片类药物滥用的政策让他们感到受到了污名化。
我们发现临床医生和患者在如何看待阿片类药物风险方面存在差异。为了改善阿片类药物治疗的知情同意过程,患者和初级保健医生需要对阿片类药物的风险有共同的理解,并参与促进患者自主性和安全性的讨论。随着诊所实施阿片类药物处方政策,临床医生必须制定有效的沟通策略,以便向患者宣传阿片类药物风险,并减少患者的污名化和歧视经历。